ClassID:

95475

C07D495/18 - CPC Classification

Classification description:

Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings Bridged systems

Recent Application in this class:
#1
20250122213
2025-04-17

OPIOID RECEPTOR MODULATORS

#2
20250092062
2025-03-20

MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE

#3
20240279233
2024-08-22

MACROCYCLIC TAK1 INHIBITORS

#4
20240101571
2024-03-28

NLRP3 MODULATORS

#5
20230382919
2023-11-30

OXA- IBOGAINE INSPIRED ANALOGUES FOR TREATMENT OF NEUROLOGICAL AND PSYCHIATRIC DISORDERS

#6
20230271976
2023-08-31

Opioid receptor modulators

#7
20230183261
2023-06-15

Macrocyclic MCL-1 Inhibitors and Methods of Use

#8
20230183258
2023-06-15

NLRP3 MODULATORS

#9
20230159509
2023-05-25

PYRIDINESULFONAMIDE DERIVATIVES AS TRAP1 MODULATORS AND USES THEREOF

#10
20220289700
2022-09-15

EPOXIDE FUNCTIONALIZED POLYAROMATIC FEEDSTOCK AND POLYMERS DERIVED THEREFROM

#11
20220259226
2022-08-18

MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE

#12
20210292339
2021-09-23

MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE

#13
20210292336
2021-09-23

NLRP3 modulators

#14
20210277019
2021-09-09

Heterocyclic compounds and their use in preventing or treating bacterial infections

#15
20210275542
2021-09-09

Heterocyclic compounds and their use in preventing or treating bacterial infections

#16
20210155637
2021-05-27

Fused pentacyclic imidazole derivatives

#17
20200345705
2020-11-05

Crystalline forms of compounds for preventing or treating sensory hair cell death

#18
20200325153
2020-10-15

Macrocyclic MCL-1 Inhibitors and Methods of Use

#19
20200095200
2020-03-26

Diindole compounds useful in treatment of nervous system disorders

#20
20200010480
2020-01-09

Macrocyclic MCL-1 Inhibitors and Methods of Use

#21
20190367535
2019-12-05

Fused pentacyclic imidazole derivatives

#22
20190144465
2019-05-16

Macrocyclic MCL-1 inhibitors and methods of use

#23
20190055264
2019-02-21

Macrocyclic MCL-1 inhibitors and methods of use

#24
20180022756
2018-01-25

Compounds and methods for preventing or treating sensory hair cell death

#25
20180002283
2018-01-04

Diindole compounds useful in treatment of nervous system disorders

#26
20170334923
2017-11-23

Opioid receptor modulators

#27
20170313720
2017-11-02

Methods for treatment of resistant cancer

#28
20170305932
2017-10-26

Fused pentacyclic imidazole derivatives

#29
20160326186
2016-11-10

Compounds and methods for preventing, treating and/or protecting against sensory hair cell death

#30
20160285009
2016-09-29

Organic Electroluminescent materials and devices

#31
20160229869
2016-08-11

Compounds and methods for preventing or treating sensory hair cell death

#32
20150225419
2015-08-13

Methods for the preparation of hydromorphone

#33
20140187792
2014-07-03

Condensed polycyclic aromatic compound, aromatic polymer, and method for synthesizing aromatic compound

#34
20120211731
2012-08-23

Adduct compound, methods for purification and preparation of fused polycyclic aromatic compound, solution for formation of organic semiconductor film, and novel alpha-diketone compound

#35
20120074336
2012-03-29

LIGHT-DRIVEN ROTARY MOLECULAR MOTORS

#36
20110236828
2011-09-29

Actinic ray-sensitive or radiation-sensitive resin composition and pattern forming method using the same

#37
20110086838
2011-04-14

Method for treating cannabinoid receptor related diseases with cannabinoid receptor ligands

#38
20110077394
2011-03-31

Light-driven rotary molecular motors

#39
20080275106
2008-11-06

Anticancer and antiprotozoal dihydroartemisinene and dihydroartemisitene dimers with desirable chemical functionalities

#40
20080227989
2008-09-18

Methyl 2,4,9-trithiaadamantane-7-carboxylate

#41
20080214643
2008-09-04

FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF, MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION

#42
20080058307
2008-03-06

Compounds as cannabinoid receptor ligands

#43
20070173650
2007-07-26

Methyl 2,4,9-trithiaadamantane-7-carboxylate

#44
20060223832
2006-10-05

Fused heterocyclic imido and amido compounds

#45
20050272799
2005-12-08

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

#46
20050192253
2005-09-01

Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function

#47
20050119228
2005-06-02

Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof